Cannabis Company Kaya Holdings, Inc. (OTCQB:KAYS)
to Postpone Annual
Shareholder and Webinar and Conference Call
Until After New Year
Postponement Due to
Focus on Negotiations for Potential Further
Expansion of Company's Cultivation Capacity;
New Date
to
be Announced
Fort
Lauderdale, FL -- December
13,
2018 -- Kaya Holdings, Inc. (OTCQB:
KAYS) announced today that it is
postponing its annual shareholder
webinar and conference call, originally scheduled for Tuesday,
December 18, 2018, until
after the New
Year to allow
for the completion of negotiations for
potential further expansion of the
Company's current cultivation canopy.
"We
regret postponing
the meeting and thank the very many people who signed up. We would
not take such action unless it was both unavoidable and worthwhile.
We have been exposed to a time sensitive opportunity
to
potentially expand our current cultivation canopy
that
requires the full and immediate attention of management. For this
reason, and because we seek to provide the best presentation of the
Company's status and plans, we have elected to postpone
the
previously announced shareholder webinar and conference
call".
The
Company will announce the new date promptly
after the
first of the year and anticipates
that it will
endeavor hold the shareholder
webinar and conference call during the first
two weeks of January 2019.
The
Company apologizes
for any
inconvenience this change may cause.
About Kaya Holdings, Inc. (www.kayaholdings.com)
and the Kaya
Shack brand (www.kayashack.com)
of licensed medical and recreational marijuana stores.
KAYS
(OTCQB:
KAYS), through subsidiaries, produces, distributes or sells
legal premium medical and recreational cannabis products, including
flower, concentrates and oils, and cannabis-infused
foods.
In 2014, KAYS, became the first publicly traded company to own and
operate a Medical Marijuana Dispensary. Since that time KAYS has
expanded and presently operates four Kaya Shack OLCC licensed
marijuana retail stores to service the legal medical and
recreational marijuana market in Oregon
(www.kayashack.com).
Additionally, in late 2017 KAYS acquired a 26-acre parcel in
Lebanon, Oregon which it has targeted for development of the Kaya
Farms Marijuana Grow Complex, and has completed the recent purchase
of the Eugene, Oregon based Sunstone Farm Facility which holds OLCC
(Oregon Liquor Control Commission) Licenses for both the production
(growing) and processing of medical and recreational marijuana
flower and cannabis concentrates/extracts/edibles.
IMPORTANT
DISCLOSURE: KAYS is planning execution of its stated business
objectives in accordance with current understanding of State and
Local Laws and Federal Enforcement Policies and Priorities as it
relates to Marijuana (as outlined in the Justice Department's U.S.
Attorney General Jeff Sessions Memo dated January 4, 2018, and
subsequent commentary from the U.S. Attorney for the District of
Oregon Billy Williams), and plans to proceed cautiously with
respect to legal and compliance issues. Potential investors and
shareholders are cautioned that KAYS and MJAI will obtain advice of
counsel prior to actualizing any portion of their business plan
(including but not limited to license applications for the
cultivation, distribution or sale of marijuana products, engaging
in said activities or acquiring existing Cannabis production/sales
operations). Advice of counsel with regard to specific activities
of KAYS, Federal, State or Local legal action or changes in Federal
Government Policy and/or State and Local Laws may adversely affect
business operations and shareholder value.
Forward Looking Statements
This press release includes statements that may constitute
"forward-looking" statements, usually containing the words
"believe," "estimate," "project," "expect" or similar expressions.
These statements are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. Factors that would cause or
contribute to such differences include, but are not limited to,
acceptance of the Company's current and future products and
services in the marketplace, the ability of the Company to develop
effective new
products and receive regulatory approvals of such products,
competitive factors, dependence upon third-party vendors, and other
risks detailed in the Company's periodic report filings with the
Securities and Exchange Commission. By making these forward-looking
statements, the Company undertakes no obligation to update these
statements for revisions or changes after the date of this
release.
For more
information contact Investor Relations: 561-210-7664